Digital Health Global Market Report 2023: Featuring Ampersand Health, Livongo Health, CogniFit, JOGO Health & More
DUBLIN, Jan. 31, 2023 /PRNewswire/ -- The "Digital Health Market: Focus on Digital Therapeutics, Distribution by Type of Solution, Type of Therapy, Purpose of Solution, Type of Business Model, Target Therapeutic Area
Global Digital Therapeutics Market Report 2021: COVID-19 Impacts, Changes and Growth to 2025 & 2030 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Digital Therapeutics Global Market Report 2021: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering. The global digital therapeu
Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring
Biotricity (NASDAQ:BTCY) is reforming the healthcare market as one of the fastest-growing companies in medtech. The company bridges the gap in remote cardiac monitoring, preventive and chronic care ma
Sister Mu Tou, the originator of heavy telemedicine: the pricing model is clever, but why is it like selling insurance?
Teladoc is the originator of internet telemedicine. The company's advantage lies in its US market share of nearly 30%, the relatively manageable costs brought about by building its own team of doctors, and its products are cheaper than competitors.
Why Goldman Sachs Is Waiting For Teladoc's Merger Story To Unfold
Teladoc Health Inc’s (NYSE: TDOC) acquisition of Livongo Health (NASDAQ: LVGO) was completed on Oct. 30 and has yet to generate impressive growth, according to Goldman Sachs. The Teladoc Health Analy
News On Livongo Health Inc. (LVGO) Now Under TDOC
*DJ News On Livongo Health Inc. (LVGO) Now Under TDOC (END) Dow Jones Newswires October 30, 2020 17:08 ET (21:08 GMT) Copyright (c) 2020 Dow Jones & Company, Inc.
BRIEF-Teladoc Health Completes Merger With Livongo
Livongo Health Inc LVGO.O :* TELADOC HEALTH COMPLETES MERGER WITH LIVONGOSource text for Eikon: Further company coverage:
NASDAQ TRADE HALT CONTINUES LVGO.O REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 A
NASDAQ TRADE HALT LVGO.O TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:51 PM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:51 P
Teladoc Shareholders Approve Merger With Livongo
Teladoc Shareholders Approve Merger With Livongo
BRIEF-Teladoc Health Inc says Transactions Contemplated By Merger Agreement Are Expected To Be Consummated On October 30
Oct 29 (Reuters) - TELADOC HEALTH INC * TELADOC HEALTH INC - TELADOC'S STOCKHOLDERS VOTED TO APPROVE ISSUANCE OF SHARES OF TELADOC COMMON STOCK TO STOCKHOLDERS OF LIVONGO HEALTH * TELADOC H
Teladoc (TDOC), Livongo Health (LVGO) transactions expected to be consummated on October 30
Teladoc (NYSE: TDOC) disclosed regarding the Livongo Health (NASDAQ: LVGO) deal:On October 29, 2020, Teladoc Health, Inc. (“Teladoc”) held a special meeting of its stockholders (the “Special Meeting”)
BRIEF-Livongo Posts Q3 Non-GAAP Net Income Per Share Of $0.16
Oct 28 (Reuters) - Livongo Health Inc : * LIVONGO REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS * Q3 REVENUE $106.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $99.3 MILLION * Q3 GAAP LOSS
12 Healthcare Stocks Moving In Wednesday's After-Market Session
Gainers Conmed (NYSE:CNMD) stock rose 9.59% to $86.95 during Wednesday's after-market session. At the close, Conmed's trading volume reached 33.4K shares. This is 13.41% of its average volume over th
Livongo Health Q3 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $106.10M Beat $98.80M Estimate
Livongo Health (NASDAQ:LVGO) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.05 by 220 percent. This is a 420 percent increase over losses of $(0.05) per
Livongo Health shares are trading lower after Piper Sandler downgraded the stock from Overweight to Neutral.
Livongo Health shares are trading lower after Piper Sandler downgraded the stock from Overweight to Neutral.
Livongo Health Price Target Raised to $143.00/Share From $55.00 by Piper Sandler
DJ Livongo Health Cut to Neutral From Overweight by Piper Sandler Ratings actions from Benzinga: https://www.benzinga.com/stock/LVGO/ratings (END) Dow Jones Newswires October 28, 2020 05:30
Piper Sandler Downgrades Livongo Health to Neutral, Raises Price Target to $143
Piper Sandler analyst Sean Wieland downgrades Livongo Health (NASDAQ:LVGO) from Overweight to Neutral and raises the price target from $55 to $143.
Earnings Scheduled For October 28, 2020
Companies Reporting Before The Bell • M/I Homes (NYSE:MHO) is estimated to report quarterly earnings at $1.44 per share on revenue of $668.17 million. • Automatic Data Processing (NASDAQ:AD
10 Biggest Price Target Changes For Wednesday
Needham raised the price target for Trade Desk Inc (NASDAQ:TTD) from $580 to $750. Trade Desk shares rose 0.1% to $651.01 in pre-market trading. Raymond James raised AutoZone, Inc. (NYSE:AZO) pric
No Data